Glenmark Pharmaceuticals Ltd - Share Price
GLENMARK
Glenmark Pharmaceuticals LtdFinancials
Glenmark Pharmaceuticals LtdNews & Updates
Indian Pharma companies sales to rise after resilience in FY21: Fitch Ratings
Jun 16,2021 08:23 AM
Most Indian pharma companies reported resilient operating performance in FY21, benefitting from gradual stabilisation after 1QFY21
Glenmark becomes one of the first firms in the UK to launch a bioequivalent version of Tiogiva Jun 15,2021
Glenmark announces interim data from PMS study on Favipiravir in India Jun 09,2021
Glenmark Pharma receives USFDA approval for Theophylline Extended-Release Tablets Jun 04,2021
Glenmark Pharma gets approval for Theophylline Tablets Jun 04,2021
Glenmark Pharmaceuticals launches Rufinamide Tablets; Stock jumps 2% Jun 01,2021
Meeting Type
Meeting Date
| Resolution Type | Description Of Resolution | IiAS Recommendation |
|---|
Peer Comparison
| Name | LTP | PE | Mar Cap | NP Qtr | Div. Yld | Sales Qtr | BV |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceuticals Industries Ltd | 668.50 | 71.95 | 160,371.55 | 327.39 | 1.12 | 3,119.04 | 104.36 |
| Divis Laboratories Ltd | 4,197.30 | 56.94 | 111,305.67 | 487.93 | 0.48 | 1,718.39 | 349.25 |
| Dr Reddys Laboratories Ltd | 5,283.90 | 40.21 | 87,906.42 | 311.50 | 0.47 | 3,313.50 | 1,020.99 |
| Cipla Ltd | 960.90 | 31.37 | 77,443.53 | 413.41 | 0.52 | 3,173.39 | 247.09 |
| Cadila Healthcare Ltd | 620.40 | 38.96 | 63,492.52 | 464.70 | 0.56 | 1,949.70 | 124.49 |
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Glenmark Pharmaceuticals LtdSummary & Reports
Glenmark Pharmaceuticals Ltd was incorporated in November 18th, 1977. The company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). It is engaged in the business of development, manufacture and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredients to regulated and semi-regulated markets. The company has several molecules in var... More
Registered Office
B/2 Mahalaxmi Chambers,22 Bhulabhai Desai Road,Mumbai, Maharashtra,400026
Tell. : +91-22-40189999
Website : http://www.glenmarkpharma.com
Email : complianceofficer@glenmarkpharma.com
Registrar Office
Karvy Selenium Tow-B, Nanakramguda, Hyderabad-500032 INDIA
Tell. : +91-40-67162222
Website : www.kfintech.com
Email : einward.ris@kfintech.com
Reports by glenmark-pharmaceuticals-ltd-share-price
Latest Release by glenmark-pharmaceuticals-ltd-share-price
Result Express
Jun 18, 2021 09:07 PM
The company’s consolidated revenue stood at Rs2,581.33cr, up 14.39% yoy and 19.2% qoq.
Shareholding Snapshot
Loading ...
| Mar - 2021 | |
|---|---|
| Promoter | - |
| Foreign | 0.00% |
| Indian | 46.63% |
| Total Promoter | 46.63% |
| Non Promoter | - |
| Institutions | 35.00% |
| Non-Institutions | 18.38% |
| Total Non-Promoter | 53.37% |
| Custodian | 0.00% |
| Total | 100% |
Corporate Action
Purpose
Board Meeting
Exp. Date
28 May 2021
Annc. Date
19 May 2021
GLENMARK PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Comp... More
Purpose
Board Meeting
Exp. Date
12 Feb 2021
Annc. Date
01 Feb 2021
GLENMARK PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Comp... More
